(RTTNews) - Abbott (ABT) has received FDA clearance for its Alinity m STI Assay test, which simultaneously detects and differentiates four common sexually transmitted infections. The Alinity m STI ...
Abbott Laboratories is adding HPV screening to its "Alinity m" family of diagnostic assays following U.S. Food & Drug Administration approval. Abbott said in a press release that the FDA approved its ...
The newly approved Alinity m high risk human papillomavirus (HPV) assay is indicated to detect HPV and for use in routine cervical cancer screening per professional medical guidelines. The FDA has ...
ABBOTT PARK, Ill., Nov. 2, 2023 /PRNewswire/ -- Abbott (NYSE: ABT) has received U.S. Food and Drug Administration (FDA) approval for its molecular human papillomavirus or HPV screening solution, ...
Expanding offerings within the Core Laboratory Diagnostics business, Abbott ABT recently announced the receipt of CE Mark for the Alinity m diagnostics system and assays. This new offering from Abbott ...
Abbott’s Alinity m Resp-4-Plex molecular assay, which was designed to test for four viruses in one test, has been authorized for emergency use by the US Food and Drug Administration (FDA). Shares of ...
More than 250 HPV tests and hundreds of different variants are commercially available globally, but majority of these tests do not meet the performance characteristic standards agreed upon in the HPV ...
The FDA urged clinical laboratories and healthcare providers to retest any patients who have recently received a positive result from two of Abbott’s PCR COVID-19 assays after identifying a heightened ...
According to the U.S. Centers for Disease Control (CDC), most sexually active adults will experience HPV infections; new test detects those HPV genotypes that could lead to cancer Abbott (ABT)'s new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback